Search and Track the Federal Register
Department or Agency:
Show:
Regulations Filed: All Dates
Between and
Full Text (optional):

[Federal Register: February 19, 2008 (Volume 73, Number 33)]
[Notices]               
[Page 9103]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19fe08-29]                         

[[Page 9103]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of Invention Described in U.S. Provisional Patent Application 
Concerning Treatment of Ischemia-Reperfusion Injury with Lipid, 
Annexin, and Lipid-Annexin Complexes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement 
is made of the availability for licensing of the invention described in 
U.S. Provisional Patent Application No. 60/786,527 entitled ``Treatment 
of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin 
Complexes,'' filed March 27, 2006. Foreign rights are also available 
(PCT/US2007/065125). The United States Government, as represented by 
the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Disclosed are lipids, annexin, and lipid-
annexin complexes for use in the prevention and/or treatment of 
ischemia-reperfusion injury and reperfusion injury associated with a 
variety of diseases and conditions. Also disclosed are therapeutic 
targets and compositions for the prevention and treatment of ischemia-
reperfusion injury and diseases and conditions associated with 
ischemia-reperfusion injury.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
 [FR Doc. E8-2980 Filed 2-15-08; 8:45 am]

BILLING CODE 3710-08-P